KOOL - Cesca Therapeutics Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20176/30/20166/30/2015
Total Revenue14,52511,92916,042
Cost of Revenue8,6869,18511,293
Gross Profit5,8392,7444,749
Operating Expenses
Research Development2,4973,2305,939
Selling General and Administrative12,58210,37913,669
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-9,240-10,865-14,859
Income from Continuing Operations
Total Other Income/Expenses Net-9,860-5,85921
Earnings Before Interest and Taxes-19,100-16,724-14,838
Interest Expense10,6681,86414
Income Before Tax-29,768-18,588-14,852
Income Tax Expense-673--
Minority Interest---
Net Income From Continuing Ops-29,095-18,588-14,852
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-29,095-18,588-14,852
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-29,095-18,588-14,852